Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector

Blood

Volumn 92, Issue 5, 1998, Pages 1512-1517

  Bohl, Delphine ^b   Salvetti, Anna ^b   Moullier, Philippe ^b   Heard, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXYCYCLINE; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEMATOCRIT; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE;

EID: 0032170592     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1512     Document Type: Article

References (35)

1. Dai Y, Roman M, Naviaux RK, Verma IM: Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 89:10892, 1992
2. Hamamori Y, Samal B, Tian J, Kedes L: Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Human Gene Ther 5:1349, 1994
3. Hamamori Y, Samal B, Tian J, Kedes L: Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest 95:1808, 1995
4. Naffakh N, Pinset C, Montarras D, Li Z, Paulin D, Danos O, Heard JM: Long-term secretion of therapeutic proteins from genetically-modified skeletal muscles. Human Gene Ther 7:11, 1996
5. Bohl D, Naffakh N, Heard JM: Long term control of erythropoietin secretion levels by tetracycline in mice transplanted with engineered primary myoblasts. Nature Med 3:299, 1997
6. Noël D, Pelegrin M, Marin M, Biard-Piechaczyk M, Ourlin JC, Mani JC, Piechczyk M: In vitro and in vivo secretion of cloned antobidies by genetically-modified myogenic cells. Human Gene Ther 8:1219, 1997
7. Setoguchi Y, Danel C, Crystal RJ: Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human eryhtropoietin gene using an adenovirus vector. Blood 84:2946, 1994
8. Tripathy SK, Goldwasser E, Lu MM, Barr E, Leiden JM: Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus, Proc Natl Acad Sci USA 91:11557, 1994
9. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune response to transgene-encoded proteins limits the stability of gene expression after injections of replication-defective adenovirus vectors. Nature Med 2:545, 1996
10. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 2:418, 1996
11. Svensson EC, Black HB, Dugger DL, Tripathy SK, Goldwasser E, Hao Z, Chu L, Leiden J: Long term erythropoietin expression in rodents and non human primates following intramuscular injection of a replicative defective adenoviral vector. Human Gene Ther 8:1797, 1997
12. Raz E, Watanabe SM, Eisenberg RA, Parr TB, Lotz M, Kipps TJ, Carson DA: Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 90:4523, 1993
13. Tripathy S, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM, Leiden JM: Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci USA 93:10876, 1996
14. Xiao X, Li J, Samulski RJ: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70:8098, 1996
15. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM: Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 3:306, 1997
16. Clark KR, Sferra TJ, Johnson PR: Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Human Gene Ther 8:659, 1997
17. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ: Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93:14082, 1996
18. Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK, Danos O: Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Human Gene Ther 8:1891, 1997
19. Herzog RW, Hagstrom JN, Kung S, Tai SJ, Wilson JM, Fisher KJ, High KA: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:5804, 1997
20. Allen JM, Debelak DJ, Reynolds TC, Miller AD: Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J Virol 71:6816, 1997
21. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766, 1995
22. Wang Y, O'Malley Jr. BW, Tasai SY, O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 91:8180, 1994
23. No D, Yao T, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci 93:3346, 1996
24. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage ML, Cerasoli F, Dennis AH, Gilman M: A humanized system for pharmacologic control of gene expression. Nature Med 2:1028, 1996
25. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547, 1992
26. Dranoff G, Jafee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
27. Salvetti A, Orève S, Chadeuf G, Favre D, Champion-Arnaud P, David-Ameline J, Moullier P: Factors influencing recombinant adeno-associated virus production. Human Gene Ther 9:695, 1998
28. Decary S, Mouly V, Butler-Browne GS: Telomere length as a tool to monitor satellite cell amplification for cell-mediated gene therapy. Human Gene Ther 7:1347, 1996
29. Sakaguchi M, Koishihara Y, Tsuda H, Fujimoto K, Shibuya K, Kawakita M, Takastuki K: The expression of functional erythropoietin receptors on an interleukin-3 dependent cell line. Biochem Biophys Res Commun 146:7, 1987
30. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM: Systemic delivery of human growth hormone by injection of genetically-modified myoblasts. Science 254:1509, 1991
31. Leroy-Viard K, Rouyer-Fessard P, Beuzard Y: Improvement of mouse β-thalassemia by recombinant human erythropoïetin. Blood 78:1596, 1991
32. Villeval JL, Rouyer-Fessard P, Blumenfeld N, Henri A, Vainchenker W, Beuzart Y: Retro virus-mediated transfer of the erythropoietin gene in hematopoietic cells improves murine beta thalassemia. Blood 84:928, 1994
33. Olivieri NF, Freedman MH, Perrine SP, Dover GJ, Sheridan B: Trial of recombinant erythropoietin: three patients with thalassemia intermedia. Blood 80:3258, 1992
34. Rachmilewitz EA, Goldfarb A, Dover G: Administration of erythropoietin to patients with beta-thalassemia intermedia: A preliminary trial. Blood 78:1145, 1988
35. Nisli G, Kavakli K, Aydinok Y, Oztop S, Cetingul N, Basak N: Recombinant erythropoietin trial in children with transfusion-dependent homozygous beta-thalassemia. Acta Haematol 98:199, 1997